Literature DB >> 23569782

Risk factors and outcomes of imipenem-resistant Acinetobacter bloodstream infection in North-Eastern Malaysia.

Zakuan Zainy Deris1, Mohd Nazri Shafei, Azian Harun.   

Abstract

OBJECTIVE: To determine the risk factors and outcomes of imipenem-resistant Acinetobacter baumannii (IRAB) bloodstream infection (BSI) cases, since there is very little publication on Acinetobacter baumannii infections from Malaysia.
METHODS: A cross sectional study of 41 cases (73.2%) of imipenem-sensitive Acinetobacter baumanii (ISAB) and 15 cases (26.8%) of IRAB was conducted in a teaching hospital which was located at North-Eastern state of Malaysia.
RESULTS: There was no independent risk factor for IRAB BSI identified but IRAB BSI was significantly associated with longer bacteraemic days [OR 1.23 (95% CI 1.01, 1.50)]. Although prior use of carbepenems and cephalosporin were higher among IRAB than ISAB group, statistically they were not significant. There was no significant difference in term of outcomes between the two groups.
CONCLUSIONS: Although statistically not significant, this analysis compliments previous publication highlighting the importance of appropriate empiric antibiotic usage in hospital especially carbepenems and need further evaluation with bigger subjects.

Entities:  

Keywords:  Acinetobacter baumannii; Bacteraemia; Multi-drug resistant; Outcomes; Risk factors

Mesh:

Substances:

Year:  2011        PMID: 23569782      PMCID: PMC3614228          DOI: 10.1016/S2221-1691(11)60050-6

Source DB:  PubMed          Journal:  Asian Pac J Trop Biomed        ISSN: 2221-1691


  10 in total

1.  Hospital outbreak caused by a carbapenem-resistant strain of Acinetobacter baumannii: patient prognosis and risk-factors for colonisation and infection.

Authors:  M del Mar Tomas; M Cartelle; S Pertega; A Beceiro; P Llinares; D Canle; F Molina; R Villanueva; J M Cisneros; G Bou
Journal:  Clin Microbiol Infect       Date:  2005-07       Impact factor: 8.067

2.  Risk-factors for the acquisition of imipenem-resistant Acinetobacter baumannii in Spain: a nationwide study.

Authors:  J M Cisneros; J Rodríguez-Baño; F Fernández-Cuenca; A Ribera; J Vila; A Pascual; L Martínez-Martínez; G Bou; J Pachón
Journal:  Clin Microbiol Infect       Date:  2005-11       Impact factor: 8.067

3.  Acquisition of imipenem-resistant Acinetobacter baumannii in a pediatric intensive care unit: A case-control study.

Authors:  Aspasia Katragkou; Maria Kotsiou; Charalampos Antachopoulos; Alexis Benos; Danai Sofianou; Maria Tamiolaki; Emmanuel Roilides
Journal:  Intensive Care Med       Date:  2006-06-21       Impact factor: 17.440

4.  The prevalence and risk factors of nosocomial Acinetobacter blood stream infections in tertiary teaching hospital in north-eastern Malaysia.

Authors:  Zakuan Zainy Deris; Azian Harun; Mahamarowi Omar; Md Radzi Johari
Journal:  Trop Biomed       Date:  2009-08       Impact factor: 0.623

5.  Outcomes and appropriateness of management of nosocomial Acinetobacter bloodstream infections at a teaching hospital in northeastern Malaysia.

Authors:  Zakuan Zainy Deris; Azian Harun; Mohd Nazri Shafei; Rosliza Abdul Rahman; Mohd Radzi Johari
Journal:  Southeast Asian J Trop Med Public Health       Date:  2009-01       Impact factor: 0.267

6.  Risk factors for nosocomial imipenem-resistant Acinetobacter baumannii infections.

Authors:  Gülseren Baran; Ayse Erbay; Hürrem Bodur; Pinar Ongürü; Esragül Akinci; Neriman Balaban; Mustafa A Cevik
Journal:  Int J Infect Dis       Date:  2007-05-21       Impact factor: 3.623

7.  An outbreak of imipenem-resistant Acinetobacter baumannii at Songklanagarind Hospital: the risk factors and patient prognosis.

Authors:  Silom Jamulitrat; Somchit Thongpiyapoom; Nonglak Suwalak
Journal:  J Med Assoc Thai       Date:  2007-10

8.  Impact of early appropriate antimicrobial therapy on survival in Acinetobacter baumannii bloodstream infections.

Authors:  Ayşe Erbay; Aysun Idil; M Gökhan Gözel; Ipek Mumcuoğlu; Neriman Balaban
Journal:  Int J Antimicrob Agents       Date:  2009-09-08       Impact factor: 5.283

9.  Risk factors for acquisition of imipenem-resistant Acinetobacter baumannii: a case-control study.

Authors:  Sang-Oh Lee; Nam Joong Kim; Sang-Ho Choi; Tae Hyong Kim; Jin-Won Chung; Jun-Hee Woo; Jiso Ryu; Yang Soo Kim
Journal:  Antimicrob Agents Chemother       Date:  2004-01       Impact factor: 5.191

10.  Attributable mortality of imipenem-resistant nosocomial Acinetobacter baumannii bloodstream infection.

Authors:  Silom Jamulitrat; Pranee Arunpan; Parichart Phainuphong
Journal:  J Med Assoc Thai       Date:  2009-03
  10 in total
  1 in total

Review 1.  Clinical and economic impact of antibiotic resistance in developing countries: A systematic review and meta-analysis.

Authors:  Raspail Carrel Founou; Luria Leslie Founou; Sabiha Yusuf Essack
Journal:  PLoS One       Date:  2017-12-21       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.